GlassScriptPhysician profile
Eleia Serrano Reyes
NPI 1245293513
$870.35
in general payments reported to CMS, 2019-2025
17 companies · $88.23 in 2025
The $88.23 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $180 · 2022: $101 · 2023: $308 · 2024: $193 · 2025: $88.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $589.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $589.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $205.37 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Lilly USA, LLC | $93.79 | 2021-2023 | Mounjaro, Jardiance |
| Astrazeneca Pharmaceuticals LP | $89.84 | 2021-2023 | Breztri |
| Novo Nordisk INC | $88.48 | 2021-2023 | Rybelsus, Ozempic |
| Exact Sciences Corporation | $85.74 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Imperative Care, INC | $76.82 | 2024 | Symphony Catheter |
| Pfizer INC. | $43.27 | 2021-2023 | |
| Dexcom, INC. | $40.99 | 2024-2025 | Dexcom G6 Transmitter |
| Novartis Pharmaceuticals Corporation | $24.83 | 2021 | |
| Amgen INC. | $19.83 | 2023 | Repatha, Otezla |
| Sanofi-Aventis U.S. LLC | $17.69 | 2021 | |
| Heartflow, INC. | $16.78 | 2024 | |
| Galderma Laboratories, L.P. | $14.92 | 2024 | Dysport |
| Inspire Medical Systems, INC. | $14.85 | 2025 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.25 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $11.50 | 2021 | |
| Dynavax Technologies Corporation | $11.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eleia Reyes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.